You are here: Home » Current Affairs » Coronavirus » News
Cadila Healthcare completes phase-2 trial of Hepatitis C drug for Covid-19
Dhanteras shopping kicks off; high prices of gold, silver may dent sales
Business Standard

FM announces Rs 900 crore grant for coronavirus vaccine research

The grant does not cover the actual cost of vaccine and distribution expenses

Coronavirus Vaccine | Coronavirus | Community Transmission

Press Trust of India  |  New Delhi 

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
Photo: Shutterstock

Finance Minister Nirmala Sitharman on Thursday announced a Rs 900 crore grant to the Department of Biotechnology for COVID-19 vaccine research.

She said the grant does not cover the actual cost of vaccine and distribution expenses, which will be made separately as and when the vaccine is available.

She also said that Rs 10,200 crore additional budget outlay will be provided towards capital and industrial expenditure for domestic defence equipment, industrial incentives and infrastructure and green energy.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Thu, November 12 2020. 16:00 IST